Technical Analysis for TVTX - Travere Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 21.86 | 3.06% | 0.65 |
TVTX closed up 3.06 percent on Thursday, February 6, 2025, on 2.01 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Feb 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
New 52 Week Closing High | Bullish | 3.06% | |
Pocket Pivot | Bullish Swing Setup | 3.06% | |
New 52 Week High | Strength | 3.06% | |
Stochastic Reached Overbought | Strength | 3.06% | |
Overbought Stochastic | Strength | 3.06% |
Alert | Time |
---|---|
Upper Bollinger Band Resistance | about 9 hours ago |
Possible NR7 | about 9 hours ago |
Rose Above Previous Day's High | about 10 hours ago |
New 52 Week High | about 11 hours ago |
Up 3% | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
- Earnings date: 02/13/2025
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Medical Genetics Kidney Disease Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Medical Genetics Kidney Disease Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.13 |
52 Week Low | 5.12 |
Average Volume | 1,265,847 |
200-Day Moving Average | 12.97 |
50-Day Moving Average | 18.85 |
20-Day Moving Average | 19.76 |
10-Day Moving Average | 20.79 |
Average True Range | 1.07 |
RSI (14) | 65.28 |
ADX | 23.85 |
+DI | 26.66 |
-DI | 12.54 |
Chandelier Exit (Long, 3 ATRs) | 18.93 |
Chandelier Exit (Short, 3 ATRs) | 20.00 |
Upper Bollinger Bands | 22.34 |
Lower Bollinger Band | 17.19 |
Percent B (%b) | 0.91 |
BandWidth | 26.03 |
MACD Line | 0.81 |
MACD Signal Line | 0.66 |
MACD Histogram | 0.1495 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 23.15 | ||||
Resistance 3 (R3) | 23.10 | 22.61 | 22.94 | ||
Resistance 2 (R2) | 22.61 | 22.28 | 22.64 | 22.86 | |
Resistance 1 (R1) | 22.24 | 22.08 | 22.43 | 22.29 | 22.79 |
Pivot Point | 21.75 | 21.75 | 21.85 | 21.78 | 21.75 |
Support 1 (S1) | 21.38 | 21.42 | 21.57 | 21.43 | 20.93 |
Support 2 (S2) | 20.89 | 21.22 | 20.92 | 20.86 | |
Support 3 (S3) | 20.52 | 20.89 | 20.79 | ||
Support 4 (S4) | 20.57 |